enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Zepbound vs. Wegovy: New clinical trial says this weight-loss ...

   www.aol.com/finance/zepbound-vs-wegovy-clinical...

   Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. ... in a 2023–24 randomized clinical trial backed by Lilly. ...

3. How Long Can You Take Semaglutide for Weight Loss? - AOL

   www.aol.com/long-semaglutide-weight-loss...

   A more recent 2024 study — also funded by Novo Nordisk — is currently the longest clinical trial on semaglutide for weight loss. It looked at almost 18,000 participants with excess weight or ...

4. ‘It’s a new era’: Weight-loss treatments significantly lower ...

   www.aol.com/weight-loss-drug-helps-significantly...

   This new study is part of a larger clinical trial that previously showed that weekly tirzepatide injections resulted in weight loss of up to 22% in adults with overweight or obesity, helping ...

5. Maridebart cafraglutide - Wikipedia

   en.wikipedia.org/wiki/MariTide

   Maridebart cafraglutide (also known as MariTide; [1] developmental name AMG 133) is an investigational drug developed by Amgen for the treatment of obesity.It is an agonist of the GLP-1 receptor (GLP-1R) and an antagonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR).

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   A prodrug of DNP, HU6, has been tested in clinical trials for weight loss and fatty liver disease. [ 22 ] Fibroblast growth factor-21 receptor agonists and drugs increasing FGF-21 activity are being investigated for obesity-related diseases; they can increase energy expenditure and several have been tested in humans.

7. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   In March 2023, a Novo Nordisk official said, based on a randomized, double-blind study (NCT03548935 [112]) funded by the company, that patients using semaglutide to lose weight regained two-thirds of their original weight loss one year (52 weeks) after discontinuing use of the drug. After two years (120 weeks), the patients retained roughly one ...

8. Lilly's weight-loss drug reduces sleep apnea severity in late ...

   www.aol.com/news/eli-lillys-weight-loss-drug...

   The trial results add to a growing body of clinical evidence that suggests popular GLP-1 drugs such as Lilly's Zepbound and Novo Nordisk's Wegovy have medical benefits beyond diabetes and weight loss.

9. Liraglutide - Wikipedia

   en.wikipedia.org/wiki/Liraglutide

   The clinical relevance of these findings is unknown. [2] In clinical trials, the rate of thyroid tumors in participants treated with liraglutide was 1.3 per 1000 participant years (4 people) compared to 1.0 per 1000 participants (1 person) in comparison groups.